ArticleTechnology in cancer research & treatment
Development and Validation of a Magnetic Resonance Imaging-Guided Adaptive Radiotherapy Workflow for Long, Continuous Planning Target Volumes.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionOwing to the limitation in the field size of the magnetic resonance (MR)-Linac, currently, tumors with a length of >20 cm cannot be treated. Thus, the present study aimed to develop an expanded magnetic resonance imaging-guided adaptive radiotherapy (MRIgART) workflow for long, continuous planning target volumes (PTVs).MethodsThe PTVs were divided into two sub_target volumes (PTV_sub1 and PTV_sub2). We established two isocenters and defined a field overlap region. By adjusting the MR scan range, devising the online and offline adaptive procedures, synchronizing the online adaptive processes, and constructing a pretreatment dose evaluation, a new MRIgART workflow for long PTVs was established. The new workflow was validated using an in-house-made MR phantom. Additionally, the ArcherQA Monte Carlo-based method, ArcCHECK phantom, and ionization chamber measurement method were used for dose verification.ResultsTwo clinical scenarios were established: (1) both PTV_sub1 and PTV_sub2 followed the adapt-to-position (ATP) workflow, and (2) PTV_sub1 followed the adapt-to-shape (ATS) workflow, whereas PTV_sub2 followed the ATP workflow. The feasibility of the proposed MRIgART workflow for long, continuous PTVs was demonstrated through three independent rounds of testing and validation for each scenario. When field overlaps were utilized, the PTV length that can be treated is 40 cm minus the length of field overlap region. The average gamma pass rates for the PTV_sub1 and PTV_sub2 adaptive plans were 95.74% and 98.63%, respectively (ArcherQA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.